Literature DB >> 24803258

Letter: Telaprevir triple therapy in chronic hepatitis C genotype 1 patients receiving haemodialysis.

J Wiegand1, B Maasoumy, P Buggisch, A Buslau, I Schiefke, T Berg, H Wedemeyer, C Sarrazin, H Hinrichsen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24803258     DOI： 10.1111/apt.12748

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  7 in total

Review 1.  Hepatitis C and kidney disease: An overview and approach to management.

Authors:  Ahmad Najib Azmi; Soek-Siam Tan; Rosmawati Mohamed
Journal:  World J Hepatol       Date:  2015-01-27

Review 2.  Management of hepatitis C in patients with chronic kidney disease.

Authors:  Roberto J Carvalho-Filho; Ana Cristina C A Feldner; Antonio Eduardo B Silva; Maria Lucia G Ferraz
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

Review 3.  Anti-hepatitis C virus drugs and kidney.

Authors:  Paul Carrier; Marie Essig; Marilyne Debette-Gratien; Denis Sautereau; Annick Rousseau; Pierre Marquet; Jérémie Jacques; Véronique Loustaud-Ratti
Journal:  World J Hepatol       Date:  2016-11-18

Review 4.  Novel Treatment of Hepatitis C Virus Infection for Patients with Renal Impairment.

Authors:  Goki Suda; Koji Ogawa; Megumi Kimura; Masato Nakai; Takuya Sho; Kenichi Morikawa; Naoya Sakamoto
Journal:  J Clin Transl Hepatol       Date:  2016-12-26

Review 5.  Treatment of hepatitis C in special populations.

Authors:  Goki Suda; Koji Ogawa; Kenichi Morikawa; Naoya Sakamoto
Journal:  J Gastroenterol       Date:  2018-01-03       Impact factor: 7.527

6.  Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus.

Authors:  Rita Chelly Felix Tavares; Ana Cristina de Castro Amaral Feldner; João Renato Rebello Pinho; Fernanda de Mello Malta; Roberto José Carvalho-Filho; Rúbia Anita Ferraz Santana; Vanessa Fusco Duarte de Castro; Gregório Tadeu Fernando Dastoli; Juliana Custódio Lima; Maria Lucia Cardoso Gomes Ferraz
Journal:  Infect Drug Resist       Date:  2018-10-25       Impact factor: 4.003

7.  Boceprevir-Based Triple Antiviral Therapy for Chronic Hepatitis C Virus Infection in Kidney-Transplant Candidates.

Authors:  Mireille Mehawej; Lionel Rostaing; Laurent Alric; Arnaud Del Bello; Jacques Izopet; Nassim Kamar
Journal:  J Transplant       Date:  2015-07-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.